Different modes of cell-killing action between DNA topoisomerase I and II inhibitors revealed by kinetic analysis. (Q55234138)

28 June 2018

title

Different modes of cell-killing action between DNA topoisomerase I and II inhibitors revealed by kinetic analysis. (English)

1 reference

28 June 2018

author name string

M Inaba

1

1 reference

28 June 2018

J Mitsuhashi

2

1 reference

28 June 2018

S Kawada

3

1 reference

28 June 2018

H Nakano

4

1 reference

28 June 2018

publication date

1 February 1994

1 reference

28 June 2018

number of pages

7

1 reference

Japanese Journal of Cancer Research

inferred from page(s)

published in

1 reference

28 June 2018

volume

85

1 reference

28 June 2018

issue

2

1 reference

28 June 2018

page(s)

187-193

1 reference

28 June 2018

DNA topoisomerase I and II in cancer chemotherapy: update and perspectives

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919418

Abrogation of etoposide-mediated cytotoxicity by cycloheximide

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919418

Cell killing action of cell cycle phase-non-specific antitumor agents is dependent on concentration--time product.

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919418

Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells.

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919418

Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919418

Kinetic analysis of cell killing effect induced by cytosine arabinoside and cisplatin in relation to cell cycle phase specificity in human colon cancer and Chinese hamster cells.

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919418

Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919418

DNA topoisomerase poisons as antitumor drugs

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919418

A model for tumor cell killing by topoisomerase poisons.

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919418

Kinetic analysis of 5-fluorouracil action against various cancer cells

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919418

Does bulk damage to DNA explain the cytostatic and cytotoxic effects of topoisomerase II inhibitors?

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919418

Cell death induced by topoisomerase inhibitors. Role of calcium in mammalian cells

30 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5919418

Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives

30 June 2018

1 reference

12 December 2020

Inhibition of protein synthesis reduces the cytotoxicity of 4'-(9-acridinylamino)methanesulfon-m-anisidide without affecting DNA breakage and DNA topoisomerase II in a murine mastocytoma cell line

1 reference

12 December 2020

UCE6, a new antitumor antibiotic with topoisomerase I mediated DNA cleavage activity, from actinomycetes

1 reference

12 December 2020

Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin

1 reference

12 December 2020

Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors

1 reference

12 December 2020

Induction of mammalian DNA topoisomerase I mediated DNA cleavage by antitumor indolocarbazole derivatives

1 reference

12 December 2020

Antitumor activities and schedule dependence of orally administered MST-16, a novel derivative of bis(2,6-dioxopiperazine)

1 reference

12 December 2020

Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons

1 reference

12 December 2020

Induction of a heat-stable topoisomerase II-DNA cleavable complex by nonintercalative terpenoides, terpentecin and clerocidin

1 reference

12 December 2020

10.1111/J.1349-7006.1994.TB02081.X

Identifiers

DOI

1 reference

28 June 2018

PMC publication ID

5919418

1 reference

28 June 2018

PubMed publication ID

8144400

1 reference

28 June 2018